Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT03988101
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT03988101
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03988101. Randomized; triple masking; primary purpose treatment. Start 2019-09-19 (actual); primary completion 2024-03-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event
- Condition
- Venous Thromboembolism
- Condition
- Dyslipidemias
- Intervention (Drug)
- Rosuvastatin 20mg
- Intervention (Drug)
- Control
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct03988101- Content hash
90bcac082609140e8da91047cfb3828bdb75247663263ac70a2c441cf103cecc